Recursion Executive and Leadership Team

Najat Khan, the Chief Executive Officer, President & Member, Board of Directors at Recursion, directs the company's overarching strategy and operational execution. Khan guides Recursion's mission to industrialize drug discovery, leveraging advanced technology to decode biology and improve patient outcomes. This leadership role involves setting the strategic vision for the organization, ensuring alignment across all departments, and fostering innovation within the Recursion Operating System. Overseeing the integration of biology, chemistry, automation, machine learning, and engineering, Khan drives the development of proprietary biological and chemical datasets. The Chief Executive Officer, President & Member, Board of Directors also navigates complex market dynamics and stakeholder relationships, ensuring Recursion's continued growth and impact in the biotechnology sector. Najat Khan's leadership is central to advancing the company's goal of radically improving the lives of patients through scientific and technological breakthroughs.

Madeleine Lyman, the Executive Business Partner To Ben Taylor. Chief Financial Officer and Sid Jain at Recursion, provides critical operational support to key financial and executive leadership. Lyman facilitates seamless communication and workflow between the Chief Financial Officer, Sid Jain, and other senior stakeholders, ensuring efficient execution of strategic initiatives. This role involves managing complex schedules, coordinating critical meetings, and preparing essential documentation to support financial planning and operational decision-making. By streamlining executive operations, Madeleine Lyman enhances the productivity of the finance function and supports the broader company objectives. The Executive Business Partner To Ben Taylor. Chief Financial Officer and Sid Jain ensures that critical administrative and logistical tasks are managed effectively, allowing senior leaders to focus on driving Recursion's mission of industrializing drug discovery and improving patient lives through technological innovation.

Daniel Benavides, the Director, Talent Acquisition & To The Chief of Staff & Chief Operating Officer at Recursion, leads the strategic acquisition of talent to support the company's growth and innovation objectives. Benavides is responsible for attracting and securing top-tier professionals across biology, chemistry, engineering, and machine learning, crucial for advancing Recursion's mission. This role involves close partnership with the Chief of Staff and Chief Operating Officer to ensure talent strategies align with operational needs and the company's expansion plans. The Director, Talent Acquisition & To The Chief of Staff & Chief Operating Officer develops and implements innovative recruitment programs, enhancing Recursion's ability to build and maintain a world-class team. Daniel Benavides's efforts are fundamental to scaling Recursion's capabilities in decoding biology and industrializing drug discovery, directly impacting the company's capacity to improve patient lives through technological advancements.

Emma Holtman, the Chief of Staff & Executive & Business Partner at Recursion, drives operational efficiency and strategic alignment across the organization. Holtman orchestrates key initiatives, manages cross-functional projects, and supports executive decision-making to advance Recursion's mission of industrializing drug discovery. This position involves close collaboration with senior leadership, including the Chief Executive Officer, to translate strategic priorities into actionable plans. The Chief of Staff & Executive & Business Partner oversees critical operational workflows, ensuring the effective integration of technology and scientific innovation. Emma Holtman's role is pivotal in optimizing internal processes and facilitating the seamless operation of Recursion's advanced infrastructure, which generates vast biological and chemical datasets. By enhancing organizational effectiveness, Holtman directly contributes to Recursion's goal of radically improving patient lives through breakthroughs in biology and chemistry.

Vicki Goodman, the Chief Medical Officer at Recursion, provides critical clinical leadership and strategic direction for the company's drug discovery and development efforts. Goodman guides the translation of Recursion's technological innovations into potential therapeutic solutions, focusing on improving patient outcomes. This role involves overseeing clinical strategy, ensuring that research and development align with medical needs and regulatory requirements. The Chief Medical Officer plays a key part in evaluating the clinical potential of novel biological insights generated by Recursion's operating system and proprietary datasets. Vicki Goodman's expertise is essential for navigating the complexities of clinical trials and advancing Recursion's mission to radically improve the lives of patients by industrializing drug discovery through advanced biology and machine learning.